Metabolic preconditioning of donor organs: Defatting fatty livers by normothermic perfusion ex vivo

Metabolic Engineering

Volumn 11, Issue 4-5, 2009, Pages 274-283

  Nagrath, Deepak ^a   Xu, Hongzhi ^a   Tanimura, Yoko ^a   Zuo, Rongjun ^a   Berthiaume, François ^a   Avila, Marco ^a   Yarmush, Rubin ^a   Yarmush, Martin L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Hepatocytes; Liver transplantation; Normothermic perfusion; Nuclear receptors; Steatosis

Indexed keywords

HEPATOCYTES; LIVER TRANSPLANTATION; NORMOTHERMIC PERFUSION; NUCLEAR RECEPTORS; STEATOSIS;

ACIDS; FATTY ACIDS; GRAFTS; METABOLISM; MOLECULAR MECHANICS; OXIDATION; TRANSCRIPTION; TRANSCRIPTION FACTORS;

LIVER;

2 [4 [2 [3 CYCLOHEXYL 1 (4 CYCLOHEXYLBUTYL)UREIDO]ETHYL]PHENYLTHIO] 2 METHYLPROPIONIC ACID; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; AMINO ACID; FATTY ACID; FORSKOLIN; HYPERICIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SCOPARONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; GENE EXPRESSION; LIPID METABOLISM; LIVER CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; FATTY LIVER; FEMALE; HEPATOCYTES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LIVER TRANSPLANTATION; PERFUSION; RATS; RATS, INBRED LEW; RATS, ZUCKER; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE DONORS;

RATTUS;

EID: 68249104194     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2009.05.005     Document Type: Article

References (52)

1. Adam R., et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc. 23 (1991) 1538-1540
2. Arai K., et al. Intrahepatic amino acid and glucose metabolism in a d-galactosamine-induced rat liver failure model. Hepatology 34 (2001) 360-371
3. Belghiti J., et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann. Surg. 229 (1999) 369-375
4. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
5. Butler A.J., et al. Successful extracorporeal porcine liver perfusion for 72 hr. Transplantation 73 (2002) 1212-1218
6. Canelo R., et al. Is a fatty liver dangerous for transplantation?. Transplant Proc. 31 (1999) 414-415
7. Chan C., et al. Hepatic tissue engineering for adjunct and temporary liver support: critical technologies. Liver Transplant. 10 (2004) 1331-1342
8. Chaudry I.H., et al. Improved mitochondrial function following ischemia and reflow by ATP-MgCl2. Am. J. Physiol. 246 (1984) R799-R804
9. D'Alessandro A.M., et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51 (1991) 157-163
10. Djouadi F., et al. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells. J. Clin. Endocrinol. Metab. 90 (2005) 1791-1797
11. Dolinsky V.W., et al. Triacylglycerol hydrolase: role in intracellular lipid metabolism. Cell Mol. Life Sci. 61 (2004) 1633-1651
12. Dominici F.P., et al. Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Horm. IGF Res. 15 (2005) 324-336
13. Dressel U., et al. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol. Endocrinol. 17 (2003) 2477-2493
14. Dunn J.C., et al. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol. Prog. 7 (1991) 237-245
15. Foy B.D., et al. A device to measure the oxygen uptake rate of attached cells: importance in bioartificial organ design. Cell Transplant. 3 (1994) 515-527
16. Fukuhara A., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
17. Fukumori T., et al. Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. Transplant Proc. 29 (1997) 412-415
18. Gilde A.J., et al. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res. 92 (2003) 518-524
19. Haider D.G., et al. Free fatty acids normalize a rosiglitazone-induced visfatin release. Am. J. Physiol. Endocrinol. Metab. 291 (2006) E885-E890
20. Kitz Kramer D., et al. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle. J. Biol. Chem. (2007)
21. Kloting N., and Kloting I. Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem. Biophys. Res. Commun. 332 (2005) 1070-1072
22. Kralisch S., et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J. Endocrinol. 185 (2005) R1-R8
23. Lankester D.L., et al. Use of cytosolic triacylglycerol hydrolysis products and of exogenous fatty acid for the synthesis of triacylglycerol secreted by cultured rat hepatocytes. J. Lipid Res. 39 (1998) 1889-1895
24. Le May C., et al. Fatty acids induce L-CPT I gene expression through a PPARalpha-independent mechanism in rat hepatoma cells. J. Nutr. 135 (2005) 2313-2319
25. Lee C.Y., et al. Functional recovery of preserved livers following warm ischemia: improvement by machine perfusion preservation. Transplantation 74 (2002) 944-951
26. Lehmann T.G., et al. Effects of three superoxide dismutase genes delivered with an adenovirus on graft function after transplantation of fatty livers in the rat. Transplantation 76 (2003) 28-37
27. Lehner R., et al. Subcellullar localization, developmental expression and characterization of a liver triacylglycerol hydrolase. Biochem. J. 338 Pt 3 (1999) 761-768
28. Luquet S., et al. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome. Biochimie 86 (2004) 833-837
29. Meirhaeghe A., et al. Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem. J. 373 (2003) 155-165
30. Nagasawa T., et al. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. Eur. J. Pharmacol. 536 (2006) 182-191
31. Nakamuta M., et al. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 16 (2005) 631-635
32. Napal L., et al. An intronic peroxisome proliferator-activated receptor-binding sequence mediates fatty acid induction of the human carnitine palmitoyltransferase 1A. J. Mol. Biol. 354 (2005) 751-759
33. Pegorier J.P., et al. Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses. Evidence for a decreased sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition after glucagon or cyclic AMP treatment. Biochem. J. 264 (1989) 93-100
34. Rennie S.M., et al. A switch in the direction of the effect of insulin on the partitioning of hepatic fatty acids for the formation of secreted triacylglycerol occurs in vivo, as predicted from studies with perfused livers. Eur. J. Biochem. 267 (2000) 935-941
35. Seglen P.O. Preparation of isolated rat liver cells. Methods Cell Biol. 13 (1976) 29-83
36. Selzner N., et al. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J. Hepatol. 44 (2006) 694-701
37. Serafin A., et al. Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. Am. J. Pathol. 161 (2002) 587-601
38. Serkova N.J., et al. Metabolic profiling of livers and blood from obese Zucker rats. J. Hepatol. 44 (2006) 956-962
39. Stefanovich P., et al. Extracorporeal plasma perfusion of cultured hepatocytes: effect of intermittent perfusion on hepatocyte function and morphology. J. Surg. Res. 66 (1996) 57-63
40. Strasberg S.M., et al. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 20 (1994) 829-838
41. Sun C.K., et al. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation 72 (2001) 1625-1631
42. Takahashi K., et al. Warm ischemia and reperfusion injury in diet-induced canine fatty livers. Transplantation 69 (2000) 2028-2034
43. Tamura K., et al. Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators. J. Toxicol. Sci. 31 (2006) 471-490
44. Tanaka J., et al. Effects of prostaglandin I2, superoxide dismutase, and catalase on ischemia-reperfusion injury in liver transplantation. ASAIO Trans. 36 (1990) M600-M603
45. Teramoto K., et al. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 56 (1993) 1076-1082
46. Teramoto K., et al. In vivo microscopic observation of fatty liver grafts after reperfusion. Transplant Proc. 26 (1994) 2391
47. Tolboom H., et al. A model for normothermic preservation of the rat liver. Tissue Eng. 13 (2007) 2143-2151
48. Wen Y., et al. Effects of fatty acid regulation on visfatin gene expression in adipocytes. Chin Med. J. (Engl.) 119 (2006) 1701-1708
49. Wiggins D., and Gibbons G.F. The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas. Biochem. J. 284 Pt 2 (1992) 457-462
50. Yarmush M.L., et al. Hepatic tissue engineering. Development of critical technologies. Ann. N Y Acad. Sci. 665 (1992) 238-252
51. Yonezawa T., et al. Visfatin is present in bovine mammary epithelial cells, lactating mammary gland and milk, and its expression is regulated by cAMP pathway. FEBS Lett. 580 (2006) 6635-6643
52. Zammit V.A., et al. Insulin stimulates triacylglycerol secretion by perfused livers from fed rats but inhibits it in livers from fasted or insulin-deficient rats implications for the relationship between hyperinsulinaemia and hypertriglyceridaemia. Eur. J. Biochem. 263 (1999) 859-864